Editorial policy

The nine rules

1. Sources are verifiable or absent. A numerical or clinical claim cites a peer-reviewed publication with a DOI that resolves on CrossRef, a trial record with an NCT number that resolves on ClinicalTrials.gov, or a primary regulatory or manufacturer page, in the same page.
2. Status is stated plainly. Retatrutide is described on every page as an investigational compound, not approved by the FDA or the EMA. Trial results are trial results, never expected effects of a research product.
3. No medical or dosing advice. Doses appear only as published trial doses with their source. Reconstitution arithmetic is laboratory preparation.
4. No reviews, no testimonials, no paid rankings. Vendor facts are what a vendor's page shows on a dated check, scored with one grid applied identically to everyone.
5. One disclosed pick. The site names OXpeptides (https://oxpeptides.com) as the vendor it would order from, shows the grid behind that choice, and discloses the link wherever it appears. It is not paid placement.
6. Research use is respected. Products discussed are laboratory chemicals labelled not for human use, and the pages say so.
7. Dates are real. Each page carries its publication and last-checked dates. A material correction is noted at the end of the page.
8. No tracking. No analytics, no advertising, no cookies, no third-party scripts.
9. Corrections within a week. A documented error reported to editor@where-to-buy-retatrutide.com is checked against the source and corrected within seven days.

Independence

The site is published by OX RESEARCH LTD, the company behind OXpeptides, and says so on every page. It has no advertising revenue, no affiliate program and no paid placements. Its interest is disclosed: it points readers to one vendor, and it shows the facts for every vendor it checked.

Scope

Legal statements describe the United States first, with the European Union, the United Kingdom and Australia where their position differs. Vendor checks cover US-facing research vendors. Other compounds appear only where a published study of another peptide illustrates a testing method relevant to retatrutide, and the compound is named.

More about the project is on the about page. The verdict starts at where to buy retatrutide in 2026.